Treatment of chronic tubulointerstitial disease: a new concept.
Hruska
Keith A
KA
Barnes-Jewish Hospital at Washington University, St. Louis, Missouri, USA. Hruska_k@kids.wustl.edu
D000328:Adult; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D007668:Kidney / Q000473:pathology; D008297:Male; D009395:Nephritis, Interstitial / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D016212:Transforming Growth Factor beta; D014517:Ureteral Obstruction / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology
C525819:BMP7 protein, human; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D018696:Neuroprotective Agents; D016212:Transforming Growth Factor beta